logo
908 Devices Launches VipIR, a 3-in-1 Handheld Analyzer for Field-Based Chemical Identification of Unknown Bulk Substances

908 Devices Launches VipIR, a 3-in-1 Handheld Analyzer for Field-Based Chemical Identification of Unknown Bulk Substances

Business Wire08-07-2025
BOSTON--(BUSINESS WIRE)-- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the launch of VipIR, a 3-in-1 handheld analyzer that sets a new standard for rapid and confident field-based chemical identification of unknown bulk solids and liquids, such as narcotics, explosives, and toxic chemicals. VipIR enables customs and border personnel and hazardous response teams to simplify workflows and eliminate guesswork, accelerating decision making on scene.
VipIR is redefining chemical analysis at the point of need with its combination of lab-grade analytical technologies, sophisticated algorithms and a simple, smart workflow that provides one confident result.
Share
At the heart of VipIR is Smart Spectral Processing (SSP), a proprietary algorithm that actively integrates data from Raman spectroscopy and FTIR (Fourier Transform Infrared) spectroscopy for analysis of complex or mixed substances from just one sample. No repositioning or repeated sampling is required. SSP uses the results of one spectroscopy technology to refine or confirm the other spectroscopy technology, delivering a more accurate and reliable chemical identification of an unknown substance.
'VipIR is redefining chemical analysis at the point of need with its combination of lab-grade analytical technologies, sophisticated algorithms and a simple, smart workflow that provides one confident result,' said Kevin J. Knopp, CEO and Co-founder, 908 Devices. 'This new chemical analyzer reinforces our commitment to providing frontline teams with next-generation tools that deliver confident, reliable answers.'
Other VipIR features include:
An expansive library of over 39,000 chemical spectra including drugs, toxic industrial materials, chemical warfare agents, explosives, and common chemicals
Unique SSP single sample interface integrates FTIR and Raman analysis; additional sampling methods include a flexible Raman probe and integrated vial holder
Built-in Wi-Fi and cellular connectivity enable fast data uploads, streamlined reporting and fleet management via the 908 Devices' Team Leader app
Rugged, lightweight design
For more information about VipIR, visit https://908devices.com/products/vipir/
About 908 Devices
908 Devices is revolutionizing chemical analysis with its simple handheld devices, addressing life-altering applications. The Company's devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers in vital health, safety and defense tech applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure, and global security threats. The Company designs and manufactures innovative products that bring together the power of complementary analytical technologies, software automation, and machine learning. For more information, visit www.908devices.com.
Forward Looking Statements for 908 Devices
This press release includes "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements, including, without limitation, statements regarding the expected uses and capabilities of the Company's products. Words such as "may," "will," "expect," "plan," "anticipate," "estimate," "intend" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are based on management's current expectations and involve known and unknown risks, uncertainties and assumptions which may cause actual results to differ materially from any results expressed or implied by any forward-looking statement, including the risks outlined under "Risk Factors" and elsewhere in the Company's filings with the Securities and Exchange Commission which are available on the SEC's website at www.sec.gov. Additional information will be made available in the Company's annual and quarterly reports and other filings that it makes from time to time with the SEC. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it cannot guarantee future results. The Company has no obligation, and does not undertake any obligation, to update or revise any forward-looking statement made in this press release to reflect changes since the date of this press release, except as may be required by law.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

3 Supercharged Stocks Flashing Strong Momentum Signals
3 Supercharged Stocks Flashing Strong Momentum Signals

Yahoo

time22 minutes ago

  • Yahoo

3 Supercharged Stocks Flashing Strong Momentum Signals

Several stocks have shown strong momentum in recent sessions as broader markets charge to all-time highs. Here's a look at some standout momentum movers that are just starting to pick up steam. 3 Momentum Names To Watch Benzinga's rankings system assigns scores to stocks based on momentum, growth, value and quality. The momentum score is a valuable metric for short-term trading strategies that aim to capture continuation of price trends. Identifying significant changes in momentum can help traders get ahead of potential changes in general stock direction. Benzinga's rankings system flagged three stocks that experienced significant changes in bullish momentum over the past week. BioXcel Therapeutics Inc (NASDAQ:BTAI) saw the biggest week-over-week jump in momentum score, moving from a score of 3.34 on Aug. 4 to a current score of 86.85. Shares of BioXcel Therapeutics, a biopharmaceutical company using AI to develop transformative medicines in neuroscience, have doubled over the past week and are up approximately 238% over the past month. BioXcel Therapeutics is currently trading well above its 50-day moving average of $2.11 and 100-day moving average of $1.92, indicating strong upward momentum. Key resistance is observed near the recent high of $7.36, while support can be identified around $6.67. Telos Corp (NASDAQ:TLS) also saw a strong surge in the momentum rankings this week, with a current score of 84.27, up from last week's score of 16.25. Multiple analysts lifted price targets ranging from $4 to $6 this week with shares up about 125% over the past five trading sessions. Telos is a provider of cyber, cloud and enterprise security solutions. The stock is currently trading well above its 50-day ($2.85), 100-day ($2.69) and 200-day ($3.02) moving averages, indicating a bullish trend and potential support levels at these averages. Jumia Technologies (NYSE:JMIA) saw its momentum score climb from 21.01 on Aug. 4 to 87.91 this week with shares up about 63% over the past week, according to Benzinga Pro. Jumia operates a pan-African e-commerce platform. The company is often referred to as the 'Amazon of Africa.' The stock is above its 50-day moving average of $4.22, indicating a bullish trend, while the 100-day and 200-day moving averages at $3.39 and $3.58, respectively, suggest strong support levels. Resistance is noted near the recent high of $7.85, which could act as a barrier for further upward movement. Price Actions: At the time of publication, BioXcel shares were down 12.65% at $5.94, while Telos shares were up 6.01% at $5.56 and Jumia shares were up 5.93% at $7.68, according to Benzinga Pro. Read Next: Bessent Wants Aggressive Fed Rate Cuts: 'We Should Be 150-175 Points Lower' Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet Photo: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article 3 Supercharged Stocks Flashing Strong Momentum Signals originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Light & Wonder Faces Target Cuts as Analysts Eye EBITDA Risks, Despite Buy Ratings
Light & Wonder Faces Target Cuts as Analysts Eye EBITDA Risks, Despite Buy Ratings

Yahoo

time22 minutes ago

  • Yahoo

Light & Wonder Faces Target Cuts as Analysts Eye EBITDA Risks, Despite Buy Ratings

Light & Wonder Inc. (NASDAQ: LNW) is one of the best cheap growth stocks to buy according to analysts. On August 8, 2025, Benchmark analyst Mike Hickey maintained a Buy rating on the stock but trimmed his price target from $100 to $90. One day earlier, on August 7, JPMorgan downgraded Light & Wonder from Overweight to Neutral and lowered its price target from $108 to $95. JPMorgan analysts expressed concern about the company's ability to meet its full-year 2025 EBITDA target through organic growth alone. The updated guidance includes EBITDA contributions from a recent acquisition. To hit the midpoint of that target, Light & Wonder would need to grow EBITDA by about 15% in the second half of 2025, a noticeable acceleration from its reported growth of 11% in Q1 and 7% in Q2. The firm also flagged uncertainty around free cash flow and leverage. Macquarie also updated its position on August 7, maintaining its Outperform rating but cutting its price target from $122 to $117. Light & Wonder Inc. (NASDAQ: LNW), headquartered in Las Vegas, Nevada, is a global developer and supplier of content and technology for the gaming and lottery industries. The company operates across three business segments: gaming, iGaming, and SciPlay, and provides hardware, systems, and digital platforms to casinos and online operators worldwide. While we acknowledge the potential of LNW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Stagwell Launches Media Platform to Drive AI Efficiencies, Appoints Global Leadership
Stagwell Launches Media Platform to Drive AI Efficiencies, Appoints Global Leadership

Yahoo

time22 minutes ago

  • Yahoo

Stagwell Launches Media Platform to Drive AI Efficiencies, Appoints Global Leadership

Stagwell Inc. (NASDAQ:STGW) is one of the best cheap growth stocks to buy according to analysts. On July 9, 2025, Stagwell announced the launch of the Stagwell Media Platform (SMP), a centralized team integrating the company's media, technology, and data investment arms under one umbrella. The platform is designed to streamline operations and enhance performance across Stagwell's global media business by leveraging AI-driven insights to optimize trading and buying strategies. Matt Adams was appointed as the Global CEO of SMP, bringing over two decades of experience in media and agency leadership. Marissa Jimenez was also named Global Chief Trading and Solutions Officer, effective July 14, signaling an emphasis on operational efficiency and innovation in media buying. SMP is expected to serve as a backbone for Stagwell's broader growth strategy, which includes delivering $80–100 million in AI-led efficiencies and driving toward its long-term revenue goal of $5 billion. Stagwell Inc. (NASDAQ:STGW), headquartered in New York City, is a digital-first marketing and communications firm. Its portfolio spans advertising, research, strategy, and media services across dozens of brands. The company positions itself at the intersection of creativity and data, delivering marketing transformation for clients globally. While we acknowledge the potential of STGW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store